Senior insider sale
See Remarks at BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$23.74M
324.22K shares
KUMAR NEIL plans to sell 324.22K shares of BRIDGEBIO PHARMA, INC. valued at approximately $23.74M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Units
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/16/2026 | Restricted Stock Units N/A | 28.05K | — |
| Total | 28.05K | ||
Completed
Units to sell
20K
Market value
$1.44M
Units to sell
20K
Market value
$1.44M
Units to sell
20K
Market value
$1.44M
Units to sell
20K
Market value
$1.44M
Units to sell
20K
Market value
$1.54M
Units to sell
20K
Market value
$1.54M
Units to sell
20K
Market value
$1.48M
Units to sell
20K
Market value
$1.48M
Units to sell
30.01K
Market value
$2.24M
Units to sell
20K
Market value
$1.47M
Units to sell
20K
Market value
$1.47M
Units to sell
20K
Market value
$1.49M
Units to sell
20K
Market value
$1.49M
Units to sell
26.16K
Market value
$1.72M
Planned — Approximate Date
Units to sell
28.05K
Market value
$2.07M
Units
324.22K
Value
$23.74M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/11/2026 | 20K | $1.44M | — | Completed |
2/11/2026 | 20K | $1.44M | — | Completed |
2/10/2026 | 20K | $1.44M | — | Completed |
2/10/2026 | 20K | $1.44M | — | Completed |
1/9/2026 | 20K | $1.54M | — | Completed |
1/9/2026 | 20K | $1.54M | — | Completed |
1/8/2026 | 20K | $1.48M | — | Completed |
1/8/2026 | 20K | $1.48M | — | Completed |
12/15/2025 | 30.01K | $2.24M | — | Completed |
12/5/2025 | 20K | $1.47M | — | Completed |
12/5/2025 | 20K | $1.47M | — | Completed |
12/4/2025 | 20K | $1.49M | — | Completed |
12/4/2025 | 20K | $1.49M | — | Completed |
11/20/2025 | 26.16K | $1.72M | — | Completed |
| Planned — Approximate Date | ||||
2/19/2026 | 28.05K | $2.07M | NASDAQ | Planned |
| Total | 324.22K | $23.74M | ||